GT Biopharma, Inc. (GTBP)

0.665 -0.02 (-2.21%) USD  |  NASDAQ  |  Jan 09, 11:34
More

GT Biopharma Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade